After culturing with 5% (vol/vol) CO2at 37C for 72h, the supernatant was separated for cytokine detection. gene, was built. Then recombinantB.subtilisdisplaying the CLE on the spore surface was developed by homologous recombination. Mice were immunized by oral route withB.subtilis168CLE,B.subtilis168, or phosphatebuffered saline (PBS) as control. Results showed that the IgG antibodies and cytokine (IL4, IFN) levels in theB.subtilis168CLE group were significantly higher than the control groups. This study demonstrates thatB.subtilis168CLE can generate specific systemic immune and mucosal immune responses and is a potential vaccine candidate against PEDV infection. Porcine epidemic diarrhoea virus infects pigs of all ages, causing significant economic losses to the swine industry worldwide. This study constructed a recombinantB.subtilis168CLE displaying the PEDVCOE on the spore surface. It can generate specific systemic immune and mucosal immune responses and is a potential vaccine candidate against PEDV infection. == INTRODUCTION == Diarrhoea is a common concern in pigs, causing significant economic losses to the swine industry worldwide. The etiological agents of diarrhoea are varied, and the most common causal agent is the porcine epidemic diarrhoea virus (PEDV) (Zhang et al.,2013,2019), resulting in acute diarrhoea, vomiting, dehydration, and high mortality in newborn piglets (Jung et al.,2020). Classical PEDV was first discovered in England (Wood,1977) and Belgium (Pensaert & de Bouck,1978) in the late 1970s, and it later spread to Asia (Dai et al.,2018; Sun et al.,2016). In late 2010, the reemergence of highly virulent PEDV caused large outbreaks in which suckling piglets had a high mortality (Sun et al.,2012). PEDV is transmitted primarily via faecaloral routes (Alonso et al.,2014), and the excrement and/or vomit of sick NB-598 Maleate pigs, as well as transport vehicles (Lowe et al.,2014) and feed (Dee et al.,2014) may serve as the transmission vectors. Therefore, it is easy to cause an epidemic spread in NB-598 Maleate the whole farm. PEDV is a member of the genusAlphacoronavirus, family Coronaviridae, order Nidovirales, and has a singlestranded positivesense RNA genome of about 28 kb that codes for 16 nonstructural proteins NB-598 Maleate (Nsp1Nsp16), an accessory protein ORF3, and four structural proteins known as spike (S), envelope (E), membrane (M), and nucleocapsid (N) proteins (Kocherhans et al.,2001). The S protein is located on the outer surface of the virion, forms trimers (Gallagher & Buchmeier,2001), and consists of two subunits: S1 [amino acids (aa) 1726 based on PEDV CV777] and S2 (aa 7271386) (Jung et al.,2020). The Nterminal region of the S1 domain recognizes the pAPN receptor (Li et al.,2016,2017) and is often considered as a vaccine antigen (Makadiya et al.,2016; Thavorasak et al.,2022). Previous reports have demonstrated that the CO26K equivalent (COE) region (aa 499638) of the PEDV spike protein contains the main neutralizing epitope of the virus (Bae et al.,2003; Chang et al.,2002). Recently, Rabbit polyclonal to AMAC1 the use of biological vectors to express or display COE to develop a PEDV vaccine is an area of interest (Hou et al.,2018; Wang et al.,2017,2018,2019; Yu et al.,2017). Epidemic PEDV strains have high intestinal pathogenicity and can infect the whole intestinal villus epithelial cells of piglets, causing the damage to intestinal epithelium barrier (Jung et NB-598 Maleate al.,2015). Therefore, vaccines that trigger effective mucosal immune response can defend against PEDV infection (Hou et al.,2018). However, parenterally administered live attenuated/inactivated vaccines do not induce effective mucosal immunity against PEDV (Song et al.,2007,2015), and commercialized PEDV vaccines derived from classical PEDV are ineffective against epidemic strains (Tseng et al.,2021). In addition, the way of injection immunization increases pain associated with vaccination (RosalesMendoza & Angulo,2015), which raises the possibility of diarrhoea in pigs. As a result, it is necessary to develop a new oral, needlefree vaccine based on epidemic PEDV strains. It is often difficult to develop an effective oral vaccine due to unfavourable physicochemical properties of protein antigens, which usually degrade in the gastrointestinal tract and cause poor transport across the intestinal tract (RosalesMendoza & Angulo,2015). Fortunately,B.subtilisspores are apposite delivery vehicles to protect antigens from extreme environment in gut.B.subtilisspores offer several advantages in anchoring heterologous proteins to develop an oral vaccine: (i) spores are safe becauseB.subtilisis used as a probiotic for both human and animal consumption and has been granted generally recognized as safe (GRAS) status by the United States Food and Drug Administration (RosalesMendoza et al.,2016); (ii) the strong resistance of the spores improves the stability of the fused protein in complex environments (Chen et al.,2015); (iii) spores can be produced at low cost and do not require refrigerated storage and transport (RosalesMendoza & Angulo,2015); (iv) needlefree vaccines are convenient, painless and can boost immune responses on the mucosa as well as the systemic levels (Belyakov & Ahlers,2009); (v) In light of the poor immunogenicity of some orally administered antigens, it is of special importance that spores exert adjuvant activity (Barnes et.